| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/10/2013 | CN101871944B Qualitative detection method of tea geometrid nuclear polyhedrosis virus |
| 07/10/2013 | CN101426817B Antagonist anti-cd40 antibody pharmaceutical compositions |
| 07/10/2013 | CN101386864B Nucleic acid molecules encoding a branching enzyme comprising bacteria of the genus neisseria and method for producing alpha-1.6-branched alpha-1, 4-glucanes |
| 07/10/2013 | CN101346396B G protein coupling acceptor antagonist for preventing and treating alzheimer's disease and use thereof |
| 07/10/2013 | CN101094868B Humanized anti-beta7 antagonists and uses therefor |
| 07/09/2013 | USRE44359 Nucleic acid molecules encoding anti-P-selectin antibodies |
| 07/09/2013 | US8481752 Fluorescent imaging with substituted cyanine dyes |
| 07/09/2013 | US8481690 Methods for detecting symmetrical dimethylarginine |
| 07/09/2013 | US8481689 Antibody specifically binding to c-Met and methods of use |
| 07/09/2013 | US8481688 Anti-FGFR2 antibodies |
| 07/09/2013 | US8481687 Anti-ErbB3 antibodies |
| 07/09/2013 | US8481686 Antibodies that bind stresscopin peptides |
| 07/09/2013 | US8481684 Antigen associated with the neovasculature of tumour metastases |
| 07/09/2013 | US8481683 Human antibodies that bind CD22 and uses thereof |
| 07/09/2013 | US8481676 Protein and production process and use thereof |
| 07/09/2013 | US8481485 Insulin analogs |
| 07/09/2013 | US8481314 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) |
| 07/09/2013 | US8481290 Antibody specific for a chondroitin sulphate epitope |
| 07/09/2013 | US8481041 Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy |
| 07/09/2013 | US8481038 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
| 07/09/2013 | US8481037 Recombinant IL-9 antibodies and uses thereof |
| 07/09/2013 | US8481036 Treatment of chronic prostatitis |
| 07/09/2013 | US8481035 Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A |
| 07/09/2013 | US8481034 Anti-VEGFR-3 antibody compositions |
| 07/09/2013 | US8481031 Methods and compositions using Klotho-FGF fusion polypeptides |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | CA2574821C Her2 antibody composition |
| 07/09/2013 | CA2532742C Use of a pak inhibitor for the treatment of a joint disease |
| 07/09/2013 | CA2506538C Bacterial superantigen vaccines |
| 07/09/2013 | CA2506127C Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/04/2013 | WO2013102123A2 Aglycosylated human antibody and fusion protein and uses thereof |
| 07/04/2013 | WO2013102042A2 Dual specific binding proteins directed against il-13 and/or il-17 |
| 07/04/2013 | WO2013101993A2 Dual variable domain immunoglobulins and uses thereof |
| 07/04/2013 | WO2013101972A2 Dual variable domain immunoglobulins and uses thereof |
| 07/04/2013 | WO2013101909A1 Light chain-bridged bispecific antibody |
| 07/04/2013 | WO2013101771A2 Compositions and method for treating autoimmune diseases |
| 07/04/2013 | WO2013101451A1 Method of treating alvelor bone loss through the use of anti-sclerostin antibodies |
| 07/04/2013 | WO2013100702A1 Immunoglobulin fc variants |
| 07/04/2013 | WO2013100534A1 Protein complex and method of preparing same |
| 07/04/2013 | WO2013098420A1 Method of isolating human antibodies |
| 07/04/2013 | WO2013098419A1 Method of providing monoclonal auto-antibodies with desired specificity |
| 07/04/2013 | WO2013071127A8 Monoclonal antibodies against serotransferrin antigens, and uses therefor |
| 07/04/2013 | WO2013066780A3 Methods for reducing the frequency and severity of acute exacerbations of asthma |
| 07/04/2013 | WO2013056250A3 Cxcr4 inhibiting carriers for nucleic acid delivery |
| 07/04/2013 | WO2013049362A3 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 07/04/2013 | WO2012125733A3 Antibody screening methods |
| 07/04/2013 | WO2012048332A3 A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use |
| 07/04/2013 | US20130174288 Antibodies for the treatment of hiv |
| 07/04/2013 | US20130172536 Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof |
| 07/04/2013 | US20130172535 Process for protein extraction |
| 07/04/2013 | US20130172534 Antibodies to ox-2/cd200 and uses thereof |
| 07/04/2013 | US20130172533 Humanized anti-human cd34 monoclonal antibody and uses thereof |
| 07/04/2013 | US20130172530 Novel JNK Inhibitor Molecules |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130171728 Interleukin-1 Alpha Antibodies and Methods of Use |
| 07/04/2013 | US20130171727 T1r taste receptors and genes encoding same |
| 07/04/2013 | US20130171695 Human Anti-B7RP1 Neutralizing Antibodies |
| 07/04/2013 | US20130171670 Diagnosis and monitoring of inflammation, ischemia and appendicitis |
| 07/04/2013 | US20130171669 Porous membranes having a hydrophilic coating and methods for their preparation and use |
| 07/04/2013 | US20130171187 Glucan-based vaccines |
| 07/04/2013 | US20130171176 Anthracycline-Antibody Conjugates for Cancer Therapy |
| 07/04/2013 | US20130171174 Anti-human epidermal growth factor receptor antibody and uses thereof |
| 07/04/2013 | US20130171170 Antibodies and immunoconjugates and uses therefor |
| 07/04/2013 | US20130171169 Human cytomegalovirus neutralising antibodies and use thereof |
| 07/04/2013 | US20130171168 Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors |
| 07/04/2013 | US20130171165 Preparation of scfv antibody fragments |
| 07/04/2013 | US20130171160 Antibodies directed to angiopoietin-2 and uses thereof |
| 07/04/2013 | US20130171157 NOGO Receptor-Mediated Blockade of Axonal Growth |
| 07/04/2013 | US20130171155 Inhibitors Of Complement Activation |
| 07/04/2013 | US20130171154 Anti-cd38 antibodies |
| 07/04/2013 | US20130171153 Proteins that bind pi16 and uses thereof |
| 07/04/2013 | US20130171152 Antibodies to muc16 and methods of use thereof |
| 07/04/2013 | US20130171150 Feline picorna virus and uses thereof |
| 07/04/2013 | US20130171149 Anti-ANGPTL3 Antibodies and Uses Thereof |
| 07/04/2013 | US20130171148 Monoclonal antibodies against her2 epitope |
| 07/04/2013 | US20130171147 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 07/04/2013 | US20130171146 Dual-specific il-1a/ il-1b antibodies |
| 07/04/2013 | US20130171145 Methods of treating liver disease |
| 07/04/2013 | US20130171143 Stable and soluble antibodies inhibiting tnf alpha |
| 07/04/2013 | US20130171140 Homodimeric protein constructs |
| 07/04/2013 | US20130171139 Ncam-vase and neurodegeneration |
| 07/04/2013 | US20130171138 Immunoglobulin Chimeric Monomer-Dimer Hybrids |
| 07/04/2013 | US20130171136 Methods of Treating Giant Cell Arteritis With Anti-TNF Alpha Antibodies |
| 07/04/2013 | US20130171132 Soluble Forms of Hendra and Nipah Virus G Glycoprotein |
| 07/04/2013 | US20130171131 Soluble Forms of Hendra and Nipah Virus G Glycoprotein |
| 07/04/2013 | US20130171130 Soluble interleukin-20 receptor |
| 07/04/2013 | US20130171096 Immunobinders directed against sclerostin |
| 07/04/2013 | US20130171095 Method for Purifying Antibodies |
| 07/04/2013 | US20130171074 Targeting compounds |
| 07/04/2013 | US20130171070 Humanized Anti-Factor D Antibodies And Uses Thereof |
| 07/04/2013 | US20130171063 Antibodies Directed to the Unprocessed Receptor Tyrosine Kinase c-Met |
| 07/04/2013 | US20130171061 Anti-human transferrin receptor antibody and uses thereof |
| 07/04/2013 | US20130171059 Dual variable domain immunoglobulins and uses thereof |
| 07/04/2013 | DE112011102412T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von mit Atemwegserkrankungen bzw. Atemwegsleiden assoziierten Erkrankungen bzw. Leiden A pharmaceutical combination composition and method for the treatment of conditions associated with respiratory diseases and respiratory ailments diseases or conditions |
| 07/04/2013 | DE112011102409T5 Verfahren zur Behandlung der Alzheimer-Krankheit A method for the treatment of Alzheimer's disease |
| 07/04/2013 | CA2855182A1 Pharmaceutical compositions for the treatment of tumours that express egfr and ganglioside n-glycolyl gm3 (neugcgm3) |
| 07/03/2013 | EP2610619A1 Hemokinin-1 receptor and hemokinin-1-derived peptide |
| 07/03/2013 | EP2610268A1 Modified antibodies with enhanced biological activities |
| 07/03/2013 | EP2610267A1 Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases |